248 related articles for article (PubMed ID: 28866430)
21. MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.
Wei C; Zhang X; He S; Liu B; Han H; Sun X
Gene; 2017 Dec; 637():25-32. PubMed ID: 28890378
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
23. MiR-205 promotes motility of ovarian cancer cells via targeting ZEB1.
Niu K; Shen W; Zhang Y; Zhao Y; Lu Y
Gene; 2015 Dec; 574(2):330-6. PubMed ID: 26275944
[TBL] [Abstract][Full Text] [Related]
24. The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer.
Zhou Y; Wang M; Wu J; Jie Z; Chang S; Shuang T
J Ovarian Res; 2015 Apr; 8():23. PubMed ID: 25887170
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.
Zhang J; Liu L; Sun Y; Xiang J; Zhou D; Wang L; Xu H; Yang X; Du N; Zhang M; Yan Q; Xi X
Oncotarget; 2016 May; 7(18):26516-34. PubMed ID: 27049921
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.
Zhang L; Li Z; Gai F; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3107-14. PubMed ID: 25955305
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
[TBL] [Abstract][Full Text] [Related]
29. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma.
Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M
J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3.
Xiu YL; Sun KX; Chen X; Chen S; Zhao Y; Guo QG; Zong ZH
Oncotarget; 2017 May; 8(19):31714-31725. PubMed ID: 28423647
[TBL] [Abstract][Full Text] [Related]
31. [The dualistic model and extraovarian origin theory of ovarian epithelial cancer].
Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2013 Apr; 48(4):310-3. PubMed ID: 23902820
[No Abstract] [Full Text] [Related]
32. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
33. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
34. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.
Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X
Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788
[TBL] [Abstract][Full Text] [Related]
35. The miR-200 Family: Versatile Players in Epithelial Ovarian Cancer.
Muralidhar GG; Barbolina MV
Int J Mol Sci; 2015 Jul; 16(8):16833-47. PubMed ID: 26213923
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA‑455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1.
Xu L; Li H; Su L; Lu Q; Liu Z
Mol Med Rep; 2017 Dec; 16(6):9777-9785. PubMed ID: 29039517
[TBL] [Abstract][Full Text] [Related]
37. The biology of ovarian cancer.
Auersperg N; Edelson MI; Mok SC; Johnson SW; Hamilton TC
Semin Oncol; 1998 Jun; 25(3):281-304. PubMed ID: 9633841
[TBL] [Abstract][Full Text] [Related]
38. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
[TBL] [Abstract][Full Text] [Related]
39. Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinoma.
Ahmed I; Karedath T; Andrews SS; Al-Azwani IK; Mohamoud YA; Querleu D; Rafii A; Malek JA
Oncotarget; 2016 Jun; 7(24):36366-36381. PubMed ID: 27119352
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs in ovarian carcinomas.
Dahiya N; Morin PJ
Endocr Relat Cancer; 2010 Mar; 17(1):F77-89. PubMed ID: 19903743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]